scholarly journals Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

2009 ◽  
pp. 1 ◽  
Author(s):  
Hans Ochs
Keyword(s):  
Replacement Therapy ◽  
Primary Immunodeficiency ◽  
Primary Immunodeficiency Disease ◽  
Subcutaneous Immunoglobulin ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement ◽  
Immunodeficiency Disease

Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease

2011 ◽  
Vol 31 (5) ◽  
pp. 299-307 ◽  
Author(s):  
Karolina Kasztalska ◽  
Maciej Ciebiada ◽  
Barbara Cebula-Obrzut ◽  
Pawet Górski
Keyword(s):  
Replacement Therapy ◽  
Intravenous Immunoglobulin ◽  
Common Variable Immunodeficiency ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement ◽  
Immunodeficiency Disease ◽  
Common Variable

scholarly journals Estimating the Cost of Immunoglobulin Replacement Therapy in Primary Immunodeficiency Patients

2017 ◽  
Vol 27 (4) ◽  
Author(s):  
Hosein Shabaninejad ◽  
Asra Asgharzadeh ◽  
Nima Rezaei ◽  
Aziz Rezapour
Keyword(s):  
Replacement Therapy ◽  
Primary Immunodeficiency ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement ◽  
The Cost

scholarly journals Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

2012 ◽  
Vol 169 (2) ◽  
pp. 172-181 ◽  
Author(s):  
J. S. Orange ◽  
B. H. Belohradsky ◽  
M. Berger ◽  
M. Borte ◽  
J. Hagan ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Clinical Outcomes ◽  
Subcutaneous Immunoglobulin ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement

Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment

2021 ◽  
Vol 42 (6) ◽  
pp. 489-494 ◽  
Author(s):  
Richard L. Wasserman
Keyword(s):  
Replacement Therapy ◽  
Primary Immunodeficiency ◽  
New Products ◽  
Relevant Literature ◽  
Clinical History ◽  
Laboratory Evaluation ◽  
Burden Of Care ◽  
Continue Treatment ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement

Background: Immunoglobulin replacement therapy (IGRT) is the foundation of treatment for the majority of patients with primary immunodeficiency. Clinical history and laboratory evaluation define the patients for whom IGRT is necessary and appropriate. During the 70 years since the first patient was treated, new products have led to the development of several modes of administration that facilitate the individualization of treatment that enables the optimization of care. Objective: The objective was to explain the assessment of candidates for IGRT and approaches to reevaluating recipients of IGRT to decide on the need to continue treatment and to review the approaches to optimize IGRT. Methods: The relevant literature was reviewed in the context of the author's experience supervising > 20,000 IGRT treatments over a 40-year period. Results: Providing the most appropriate form of IGRT for individual patients ameliorates disease and lessens the burden of care for patients with primary immunodeficiency. Conclusion: IGRT is safe and effective when used to treat patients with primary immunodeficiency who meet established and appropriate clinical and laboratory criteria.

Sign in / Sign up

Export Citation Format

Share Document